Association of prescribed Chinese herbal medicine use with risk of end-stage renal diseaseh chronic kidney disease

Kidney International

Volumn 88, Issue 6, 2015, Pages 1365-1373

  Lin, Ming Yen ^a,b,c   Chiu, Yi Wen ^a,b   Chang, Jung San ^a,b   Lin, Hung Lung ^a   Lee, Charles Tzu Chi ^d   Chiu, Guei Fen ^d   Kuo, Mei Chuan ^a,b   Wu, Ming Tsang ^d   Chen, Hung Chun ^a,b   Hwang, Shang Jyh ^a,b,e  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c INSTRUMENT TECHNOLOGY RESEARCH CENTER   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Chinese herbal medicine; Chronic kidney disease; End stage renal disease

Indexed keywords

CHINESE DRUG;

ADULT; ARTICLE; CHINESE MEDICINE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG USE; END STAGE RENAL DISEASE; EVIDENCE BASED MEDICINE; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; PROPENSITY SCORE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TAIWAN; TREATMENT OUTCOME;

EID: 84951569700     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.226     Document Type: Article

References (43)

1. Eisenberg DM, Davis RB, Ettner SL et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-1575
2. Hong CD. Complementary and alternative medicine in Korea: current status and future prospects. J Altern Complement Med 2001; 7: S33-S40
3. Chen FP, Chen TJ, Kung YY et al. Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res 2007; 7: 26
4. Yamashita H, Tsukayama H, Sugishita C. Popularity of complementary and alternative medicine in Japan: a telephone survey. Complement Ther Med 2002; 10: 84-93
5. Bent S, Ko R. Commonly used herbal medicines in the United States: a review. Am J Med 2004; 116: 478-485
6. Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med 2008; 23: 854-859
7. Ko RJ. A U.S. perspective on the adverse reactions from traditional Chinese medicines. J Chin Med Assoc 2004; 67: 109-116
8. Isnard Bagnis C, Deray G, Baumelou A et al. Herbs and the kidney. Am J Kidney Dis 2004; 44: 1-11
9. Colson CR, De Broe ME. Kidney injury from alternative medicines. Adv Chronic Kidney Dis 2005; 12: 261-275
10. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008; 74: 158-169
11. Tsai SY, Tseng HF, Tan HF et al. End-stage renal disease in Taiwan: a casecontrol study. J Epidemiol 2009; 19: 169-176
12. Guh JY, Chen HC, Tsai JF et al. Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan. Am J Kidney Dis 2007; 49: 626-633
13. Ingsathit A, Thakkinstian A, Chaiprasert A et al. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 2010; 25: 1567-1575
14. Lai MN, Lai JN, Chen PC et al. Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study. Am J Kidney Dis 2010; 55: 507-518
15. Lai MN, Wang SM, Chen PC et al. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst 2010; 102: 179-186
16. Wojcikowski K, Johnson DW, Gobe G. Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. J Lab Clin Med 2006; 147: 160-166
17. Wojcikowski K, Johnson DW, Gobe G. Medicinal herbal extracts-renal friend or foe? Part two: herbal extracts with potential renal benefits. Nephrology (Carlton) 2004; 9: 400-405
18. National Kidney Foundation. Use of Herbal Supplements in Chronic Kidney Disease. A to Z Health Guide, 2002 (date last accessed 15 July 2014; http://www.kidney.org/atoz/content/herbalsupp.cfm)
19. Burstein HJ, Gelber S, Guadagnoli E et al. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999; 340: 1733-1739
20. Strader DB, Bacon BR, Lindsay KL et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol 2002; 97: 2391-2397
21. Kassler WJ, Blanc P, Greenblatt R. The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch Intern Med 1991; 151: 2281-2288
22. Blanc PD, Trupin L, Earnest G et al. Alternative therapies among adults with a reported diagnosis of asthma or rhinosinusitis: data from a population-based survey. Chest 2001; 120: 1461-1467
23. Rao JK, Mihaliak K, Kroenke K et al. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 1999; 131: 409-416
24. Lin YH, Chen KK, Chiu JH. Use of Chinese medicine among prostate cancer patients in Taiwan: a retrospective longitudinal cohort study. Int J Urol 2011; 18: 383-386
25. Lai MN, Lai JN, Chen PC et al. Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid. Nephrology (Carlton) 2009; 14: 227-234
26. Hsieh SC, Lin IH, Tseng WL et al. Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003. Chin Med 2008; 3: 13
27. Lee GT, Ha H, Jung M et al. Delayed treatment with lithospermate B attenuates experimental diabetic renal injury. J Am Soc Nephrol 2003; 14: 709-720
28. Ahn YM, Kim SK, Lee SH et al. Renoprotective effect of Tanshinone IIA, an active component of Salvia miltiorrhiza, on rats with chronic kidney disease. Phytother Res 2010; 24: 1886-1892
29. You Z, Xin Y, Liu Y et al. Protective effect of Salvia Miltiorrhizae injection on N(G)-nitro-d-arginine induced nitric oxide deficient and oxidative damage in rat kidney. Exp Toxicol Pathol 2010; 64: 453-458
30. Lee SH, Kim YS, Lee SJ et al. The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy. J Ethnopharmacol 2011; 137: 1409-1414
31. Liu X, Wang Y, Ma C et al. Proteomic assessment of tanshinone IIA sodium sulfonate on doxorubicin induced nephropathy. Am J Chin Med 2011; 39: 395-409
32. Kim SK, Jung KH, Lee BC. Protective effect of Tanshinone IIA on the early stage of experimental diabetic nephropathy. Biol Pharm Bull 2009; 32: 220-224
33. Kang DG, Oh H, Sohn EJ et al. Lithospermic acid B isolated from Salvia miltiorrhiza ameliorates ischemia/reperfusion-induced renal injury in rats. Life Sci 2004; 75: 1801-1816
34. Liu SJ, Zhou SW. Panax notoginseng saponins attenuated cisplatininduced nephrotoxicity. Acta Pharmacol Sin 2000; 21: 257-260
35. Goto H, Shimada Y, Tanikawa K et al. Clinical evaluation of the effect of daio (rhei rhizoma) on the progression of diabetic nephropathy with overt proteinuria. Am J Chin Med 2003; 31: 267-275
36. Tsai Y-C, Tsai J-C, Chen S-C et al. Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study. Am J Kidney Dis 2014; 63: 68-75
37. Collins AJ, Chen SC, Gilbertson DT et al. CKD surveillance using administrative data: impact on the health care system. Am J Kidney Dis 2009; 53: S27-S36
38. Chen JK, Chen TT. Chinese Herbal Formulas and Applications: Pharmacological Effects & Clinical Research. Art of Medicine Press: City of Industry, CA, 2009
39. Cao M. [Wang Ang and his Variorum of medical recipes (Yi fang ji jie)]. Zhonghua Yi Shi Za Zhi 2000; 30: 179-181
40. Chien IC, Hsu JH, Lin CH et al. Prevalence of diabetes in patients with schizophrenia in Taiwan: a population-based National Health Insurance study. Schizophr Res 2009; 111: 17-22
41. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619
42. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154
43. Parsons L. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Paper presented at the Proceedings of the 26th Annual SAS Users Group International Conference. 2001.